AlphAIAlphAI — Financial news for AI agents
tipranks.comOCT 222 min read$IBM

IBM Stock Falls Despite Q3 Earnings Beat. Analysts Raise Price Targets

IBM reported Q3 2026 revenue of $17.10B, up 5% YoY, and EPS of $2.95, up 11.3%. Despite beating estimates, shares fell over 3% as CEO Krishna noted client concerns about AI spending returns. Analysts raised price targets, citing software performance and consulting trends, but some maintained Hold ratings due to estimate risks.

Original reporting
tipranks.com
Published Oct 22, 2026, 2:18 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 22, 2026, 2:52 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$IBM
Neutral
high confidence
Mentioned
$IBM
Relevance
8/10
AlphAI data visualization · based on tipranks.com
Decision brief

The 30-second read

$IBMNeutralHigh
01

Why it matters

Analyst price‑target upgrades signal confidence in longer‑term execution, yet the immediate share‑price decline reflects short‑term skepticism.

02

Market read

IBM’s earnings beat and analyst upgrades create a nuanced trade set‑up: potential for a rebound if the market digests the guidance positively.

03

What to watch

Deferred deals and component price hikes drove revenue; these may not be sustainable, tempering the upside from analyst target raises.

Relevance 8/10Novelty 8/10Timing: post‑earnings release today

Background

IBM’s Q3 results show modest growth and an earnings beat, but investor sentiment is wary of AI ROI concerns.

Company-level read

Ticker impact

$IBMNeutralHigh confidence
Context

IBM reported Q3 2026 revenue of $17.10 bn and EPS $2.95, beating expectations, while the stock fell >3% and analysts raised price targets.

Expected impact

likely modest upside as price‑target lifts could attract buying, but near‑term downside pressure from investor concerns about AI spend persists

Evidence & confidence

The earnings numbers are new and material; analyst target hikes provide a concrete catalyst, yet the stock already slipped on the news.

Market effects

Sector

Software and consulting segments may see renewed interest as IBM’s software revenue outlook is nudged higher.

Regional

U.S. large‑cap tech stocks could feel slight pressure if IBM’s AI‑spending concerns spread.

Global

Limited to investors tracking major U.S. tech earnings; no immediate global macro effect.

Counterpoint

What could challenge this read

Despite the earnings beat, the AI‑spending uncertainty could keep the stock under pressure, making a short‑term pullback plausible.

Key entities

  • Executive
    Arvind Krishna

    IBM CEO who highlighted AI‑spending concerns on the earnings call.

  • Analyst
    Goldman Sachs

    Raised IBM price target to $300, reinforcing a bullish view.

Read at source← All news

StoryIBM posts Q3 2026 revenue beat and lifts free‑cash‑flow outlook

Also covered by

6 outlets

Related articles

OCT 22
$IBMHighAI 8/10

IBM earnings analysis: questions answered and next catalysts

IBM reported Q3 2026 earnings beating estimates with revenue of $17.10B and EPS of $2.95. The company maintained its full-year revenue guidance, leading to a 6% pre-market drop in shares, which partially recovered to $248.72. Software growth accelerated to 9%, and free cash flow outlook was raised. Key concerns include the quality of software growth, mainframe cycle, and consulting segment performance. Next catalysts include Q4 and FY2026 results, 2027 guidance, and margin delivery.

investing.com3 min
OCT 22
$IBMHighAI 9/10

BMO raises IBM stock price target to $265 on software outlook

BMO Capital raised IBM's price target to $265 from $230, citing strong revenue growth but noting weak organic software growth. IBM's stock trades at $246.87, with a PEG ratio of 0.27. The company reported Q3 2026 earnings of $2.95 per share on $17.1B revenue, beating estimates. IBM raised its free cash flow guidance and adjusted its software growth outlook.

investing.com2 min
OCT 22
$IBMMedAI 8/10

IBM (IBM) stock trades down, here is why

IBM (NYSE: IBM) shares fell 2.9% after maintaining its full-year revenue growth forecast despite beating Q3 revenue and earnings estimates. Q3 revenue was $17.1B, up 4.7% YoY, with adjusted earnings of $2.95 per share. The company raised its annual free cash flow target to over $1B. The stock later recovered to a 2% loss, trading at $246.50.

markets.financialcontent.com2 min
OCT 22
$IBMHighAI 8/10

IBM’s Enterprise AI Bet Is Paying Off, And Arvind Krishna Says It’s Just Beginning

IBM CEO Arvind Krishna reported strong enterprise AI adoption driving demand for Red Hat OpenShift and hybrid cloud services. IBM's Q3 2026 revenue rose 5.7% to $17.1B, beating expectations. Krishna highlighted AI's shift to large-scale production and IBM's platforms supporting secure, efficient AI operations. Quantum computing advancements and storage gains were also noted.

crn.com3 min
OCT 22
$METAMed

AI doubts drive bond rally as Meta, IBM flash warning signs

Investors moved from tech stocks to U.S. Treasuries due to concerns about AI's sustainability and costs. The 10-year Treasury yield fell 10 bps to 5.03%. IBM shares dropped 4% despite earnings beat, citing client ROI concerns. Meta raised 2026 capex guidance to $135B-$145B, and its shares fell 6%, with credit risk rising.

tradingview.com3 min